Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report

Jpn J Clin Oncol. 2002 Jan;32(1):33-4. doi: 10.1093/jjco/hyf005.

Abstract

A variety of regimens of high-dose chemotherapy with hematopoietic stem cell support for poor risk germ cell tumors have been established. However, a series of chemotherapy steps carried out prior to the harvest sometimes leads to an insufficient number of peripheral blood stem cells. Here, we report a case of a patient who successfully underwent high-dose chemotherapy for the treatment of poor risk extragonadal germ cell tumor by receiving peripheral blood stem cell transplantation donated from his genomically identical twin brother.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Ifosfamide / administration & dosage
  • Lymphatic Metastasis
  • Male
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Risk Factors
  • Transplantation, Isogeneic
  • Treatment Outcome

Substances

  • Etoposide
  • Cisplatin
  • Ifosfamide